Skip to main content

Incidence and Predictors of Rebound Intracranial Hypertension after Transvenous Embolization of CSF-Venous Fistulas.

Publication ,  Journal Article
Schartz, D; Kranz, PG; Amrhein, TJ; Willhite, J; Gray, L; Malinzak, MD; Befera, NT
Published in: AJNR Am J Neuroradiol
April 16, 2026

BACKGROUND AND PURPOSE: CSF-venous fistula (CVF) is a common cause of spontaneous intracranial hypotension (SIH) and can be treated with transvenous embolization (TVE). Rebound intracranial hypertension (RIH) is an important periprocedural consideration after TVE and CSF leak closure. The purpose of this study was to determine the incidence and severity of postprocedural RIH among patients with CVFs treated with TVE. MATERIALS AND METHODS: This investigation was a single-center, retrospective cohort of consecutive patients treated with TVE for SIH due to a CVF. Patients were included who had early (1-3 days post-TVE procedure) clinical follow-up documenting the presence/severity of RIH. RIH was classified as absent, mild (ie, rated 1-4/10 in severity), moderate (ie, rated 5-7/10), or severe (ie, rated 8-10/10). The rate of RIH was then determined. Logistic regression analysis was used to evaluate clinical predictors of moderate-to-severe RIH and the need for eventual therapeutic lumbar puncture. RESULTS: In total, 100 consecutive patients (mean age, 59.4 years; 63% female) who underwent 105 TVE procedures for 132 CVFs were included. RIH of any severity (mild-to-severe) occurred in 80% of cases after TVE and was moderate-to-severe in 54% of cases. A therapeutic lumbar puncture was needed for RIH in 8 cases (7.6%). On multivariate regression, TVE of a single CVF (versus >1 CVF) was independently associated with the occurrence of moderate-to-severe RIH (OR, 2.8 [95% CI, 1.04-7.85], P = .04). Furthermore, higher pre-TVE opening pressure (third tertile, 17-28 cmH2O) was associated with eventual need for therapeutic lumbar puncture (OR, 5.0 [95% CI, 1.14-25.9], P = .03). CONCLUSIONS: Early RIH is common after TVE, with symptoms occurring in 80% of all cases. Approximately one-half of patients will experience moderate-to-severe RIH early after TVE. These findings underscore the value of routine early follow-up after TVE and emphasize the need for proceduralists to be familiar with management strategies for RIH.

Duke Scholars

Published In

AJNR Am J Neuroradiol

DOI

EISSN

1936-959X

Publication Date

April 16, 2026

Location

United States

Related Subject Headings

  • Nuclear Medicine & Medical Imaging
  • 3406 Physical chemistry
  • 3209 Neurosciences
  • 3202 Clinical sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Schartz, D., Kranz, P. G., Amrhein, T. J., Willhite, J., Gray, L., Malinzak, M. D., & Befera, N. T. (2026). Incidence and Predictors of Rebound Intracranial Hypertension after Transvenous Embolization of CSF-Venous Fistulas. AJNR Am J Neuroradiol. https://doi.org/10.3174/ajnr.A9080
Schartz, Derrek, Peter G. Kranz, Timothy J. Amrhein, Jay Willhite, Linda Gray, Michael D. Malinzak, and Nicholas T. Befera. “Incidence and Predictors of Rebound Intracranial Hypertension after Transvenous Embolization of CSF-Venous Fistulas.AJNR Am J Neuroradiol, April 16, 2026. https://doi.org/10.3174/ajnr.A9080.
Schartz D, Kranz PG, Amrhein TJ, Willhite J, Gray L, Malinzak MD, et al. Incidence and Predictors of Rebound Intracranial Hypertension after Transvenous Embolization of CSF-Venous Fistulas. AJNR Am J Neuroradiol. 2026 Apr 16;
Schartz, Derrek, et al. “Incidence and Predictors of Rebound Intracranial Hypertension after Transvenous Embolization of CSF-Venous Fistulas.AJNR Am J Neuroradiol, Apr. 2026. Pubmed, doi:10.3174/ajnr.A9080.
Schartz D, Kranz PG, Amrhein TJ, Willhite J, Gray L, Malinzak MD, Befera NT. Incidence and Predictors of Rebound Intracranial Hypertension after Transvenous Embolization of CSF-Venous Fistulas. AJNR Am J Neuroradiol. 2026 Apr 16;

Published In

AJNR Am J Neuroradiol

DOI

EISSN

1936-959X

Publication Date

April 16, 2026

Location

United States

Related Subject Headings

  • Nuclear Medicine & Medical Imaging
  • 3406 Physical chemistry
  • 3209 Neurosciences
  • 3202 Clinical sciences